Table 7 Prevalence of metabolic syndrome in Iran based on WHO criteria
From: Prevalence of metabolic syndrome and its components in Iran: an updated meta-analysis
Criteria | Categories | No. study | Pooled prevalence (% 95 CI) | Heterogeneity assessment between studies | Publication bias assessments | ||||
|---|---|---|---|---|---|---|---|---|---|
I2 | P value | B | SE | P value | |||||
WHO | Overall | 7 | 25% (19 − 31%) | 98.58% | < 0.001 | -0.69 | 2.365 | 0.7714 | |
Sex | Female | 6 | 27% (20 − 34%) | 98.02% | < 0.001 | 4.09 | 2.900 | 0.1582 | |
Male | 6 | 29% (23 − 37%) | 97.54% | < 0.001 | 3.44 | 1.064 | 0.0012 | ||
Age | 30–65 | 5 | 25% (19 − 31%) | 98.48% | < 0.001 | -0.69 | 2.365 | 0.7714 | |
> 65 | 1 | 42% (38 − 46%) | - | - | |||||
Province | Tehran | 4 | 29% (16 − 43%) | 99.17% | < 0.001 | -0.69 | 2.365 | 0.7714 | |
Qazvin | 1 | 27% (24 − 30%) | - | - | |||||
Fars | 1 | 23% (22 − 24%) | - | - | |||||
Semnan | 1 | 10% (6 − 16%) | - | - | |||||
Components | WHR or BMI | 6 | 60% (45 − 75%) | 99.74% | < 0.001 | -1.86 | 3.546 | 0.6005 | |
IFG | 6 | 37% (25 − 50%) | 99.64% | < 0.001 | -1.01 | 4.436 | 0.8191 | ||
TG | 6 | 53% (51 − 56%) | 86.58% | < 0.001 | -0.51 | 0.966 | 0.6010 | ||
HDL | 4 | 30% (17 − 46%) | 99.17% | < 0.001 | -3.11 | 4.665 | 0.5054 | ||
BP | 4 | 30% (20 − 41%) | 99.44% | < 0.001 | 2.50 | 7.942 | 0.7532 | ||